← Eichor
Condition: Dermatomyositis Dm Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Dermatomyositis Dm

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Safety and Efficacy of ULSC on Disease Severity and Steroid Tapering in Participants With Dermatomyositis/ Polymyositis
Phase 2/Phase 3 · 2 location(s) · Restem, LLC. · NCT07160205Phase 1b Trial of RAY121 in Immunological Diseases (RAINBOW Trial)
Phase 1 · 77 location(s) · Chugai Pharmaceutical · NCT06371417A Study to Understand How the Study Medicine (PF-06823859) Works in People With Active Idiopathic Inflammatory Myopathie
Phase 3 · 146 location(s) · Pfizer · NCT05895786BCMA-CD19 cCAR-T for the Treatment of Refractory Inflammatory Myopathy
Phase 1 · 1 location(s) · iCell Gene Therapeutics · NCT07715136Severity Factors of Dermatomyositis in the Caribbean Population - DM-ANTILLES
Phase N/A · 1 location(s) · Centre Hospitalier Universitaire de la Guadeloupe · NCT07265999FAST for DM - Fatty Acid Supplementation Trial (FAST) for Dermatomyositis (DM)
Phase 2 · 1 location(s) · National Institute of Environmental Health Sciences (NIEHS) · NCT07111065RCT of Tocilizumab for Anti-MDA5+DM
NA · 1 location(s) · Peking Union Medical College Hospital · NCT07377058
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.